Company Expresses Comfort with 2Q and Full Year 2009 External
Expectations
Regulatory News:
Colgate-Palmolive Company (NYSE:CL) today reported net income and
diluted earnings per share in first quarter 2009 of $507.9 million and
$.97, respectively. Reported net income and diluted earnings per share
in first quarter 2008 were $466.5 million and $.86, respectively, which
included $21.2 million of aftertax charges ($.04 per diluted share)
related to the 2004 Restructuring Program. Excluding restructuring
charges (which pertain only to 2008), net income and diluted earnings
per share increased 4% and 8%, respectively.
Worldwide sales declined 5.5% during the first quarter to $3,502.8
million and unit volume declined 0.5%. Excluding divested businesses,
worldwide sales declined 5.0% and unit volume was flat with the year ago
period. Organic sales (excluding foreign exchange, acquisitions and
divestments) grew 8.0%. Global pricing increased 8.0% and foreign
exchange was negative 13.0%.
Gross profit margin as reported increased to 57.5% in first quarter 2009
from 56.6% in first quarter 2008. Excluding restructuring charges in
2008, gross profit margin increased 20 basis points to 57.5% in first
quarter 2009 from 57.3% in first quarter 2008, reflecting the benefits
of increased pricing and aggressive cost-savings programs, which more
than offset the impact of higher raw and packaging material costs.
Selling, general and administrative expenses were 33.9% and 36.3% of net
sales in first quarter 2009 and 2008, respectively. Excluding
restructuring charges in 2008, selling, general and administrative
expenses decreased to 33.9% of net sales in first quarter 2009 from
36.0% of net sales in first quarter 2008. Worldwide advertising costs
declined 210 basis points as a percentage to sales brought about by
lower media rates in many areas of the world and reduced levels of
spending in line with competition.
As reported, operating profit was $811.4 million and $745.7 million in
first quarter 2009 and 2008, respectively. Excluding restructuring
charges in 2008, operating profit rose 4% to $811.4 million in first
quarter 2009 from $784.1 million in first quarter 2008, increasing to
23.2% from 21.1% as a percentage to sales.
Net cash provided by operations year to date increased by a strong 21%
to $690.2 million. Working capital increased slightly to 1.4% of sales
versus 0.8% in the comparable 2008 period, as reductions in receivable
and inventory days outstanding were offset by a reduced level of
payables.
Ian Cook, Chairman, President and Chief Executive Officer, commented on
the results excluding restructuring charges, “We are delighted to begin
2009 with continued strong top-line momentum with organic sales
increasing 8.0%. Also, our gross margin, operating margin and net profit
as a percent to sales increased during the quarter, despite difficult
economic conditions worldwide. Our cost-cutting and efficiency programs
as well as increased pricing more than offset the impact during the
quarter of higher raw and packaging material costs worldwide and the
strengthening dollar.
“Value-added new products at various price points across categories
continue to drive market share gains worldwide. Colgate maintained its
global leadership share in toothpaste of 44.4% and strengthened its
global leadership in manual toothbrushes with its global market share in
that category reaching a record 30.8% year to date.”
Mr. Cook concluded, “Looking ahead, we have a very full new product
pipeline for the balance of the year, which should contribute to
positive unit volume growth in the second quarter and for the full year.
We expect our strong organic sales growth to continue, driven by both
positive volume and higher pricing.
“The benefits of recently easing commodity and oil prices have begun to
flow through and should build as the year goes on. This, coupled with
the higher pricing and our ongoing aggressive savings programs, should
offset the expected impact of the stronger dollar on raw and packaging
material costs, indicating that gross profit margin should increase as
the year progresses and be up at least at the high end of our targeted
range of 75 to 125 basis points for the full year 2009. Overall, we are
comfortable with external profit expectations for both the second
quarter and the year.”
As required, the Company adopted Financial Accounting Standards Board
Statement No. 160, "Noncontrolling Interests in Consolidated Financial
Statements - An Amendment of ARB no. 51", on January 1, 2009. As a
result of the adoption, certain prior period amounts were reclassified
within the Condensed Consolidated Statements of Income and Balance
Sheets. While the reclassification had no impact on Net income or
earnings per common share, it did impact the previously reported
Operating profit and effective tax rate. Refer to Table 2 for a
reconciliation to previously reported 2008 amounts.
At 11:00 a.m. ET today, Colgate will host a conference call to elaborate
on first quarter results. To access this call as a webcast, please go to
Colgate’s web site at http://www.colgate.com.
The following are comments about divisional performance. See attached
Geographic Sales Analysis and Segment Information schedules for
additional information on divisional sales and operating profit.
North America (21% of Company Sales)
North American sales as reported grew 3.0% in the first quarter. Unit
volume increased 2.0% with 3.0% higher pricing and 2.0% negative foreign
exchange. Organic sales grew 5.0% during the quarter. North American
operating profit increased 17% during the quarter due to higher sales
and moderating raw and packaging material costs more than offsetting
increased advertising.
In the U.S., new product launches are contributing to market share gains
across categories. Market share gains year to date were seen in
toothpaste, manual toothbrushes, power toothbrushes, liquid hand soap,
body washes, hand dish liquid and liquid cleaners. In oral care, Colgate
Max Fresh with Mouthwash Beads, Colgate Sensitive and Colgate Max White
with Mini Bright Strips toothpastes contributed to the share gains.
Colgate’s toothpaste market share reached 36.9% year to date, up 0.5
share points versus year ago. Colgate’s share of the manual toothbrush
market reached a record 27.8% year to date, up 0.7 share points versus
year ago, fueled by the success of Colgate 360° Deep Clean, Colgate Max
Fresh and Colgate Max White manual toothbrushes.
Successful new products contributing to growth in the U.S. in other
categories include Colgate 360° Sonic Power battery toothbrush, Softsoap
Body Butter Apricot Scrub and Irish Spring Hair and Body and Cool Relief
body washes, Softsoap Ensembles liquid hand soap, Palmolive Pure + Clear
and Ajax Lime with Bleach Alternative dish liquids and Colgate Wisp, a
first of its kind mini-brush with a breath freshening bead that is used
without water, designed for on-the-go teeth cleaning and breath
freshening.
Looking ahead, new product activity in the U.S. planned for second
quarter 2009 includes full distribution and advertising support behind
Colgate Wisp mini-brush and Colgate Sensitive Enamel Protect toothpaste.
Latin America (26% of Company Sales)
Latin American sales declined 3.5% and unit volume increased 1.5%.
Volume gains were led by Brazil, Venezuela, Colombia and Argentina.
Higher pricing added 15.5% while foreign exchange was negative 20.5%.
Organic sales for Latin America grew 17.0% during the quarter. Latin
American operating profit increased 9% during the quarter due to higher
pricing and lower advertising costs, partially offset by negative
foreign exchange and higher raw and packaging material costs.
Colgate continues to build its strong leadership in oral care throughout
Latin America with its regional toothpaste market share at a record high
year to date, driven by market share gains in nearly every country.
Strong sales of premium-priced offerings such as Colgate Total
Professional Clean, Colgate Total Professional Sensitive and Colgate Max
Fresh Night toothpastes drove share gains throughout the region. In
Brazil, for example, Colgate’s toothpaste market share reached 69.9%
year to date, up 100 basis points versus year ago. Colgate’s leading
share of the manual toothbrush market for the region is at a record high
year to date at 40.9%, up 250 basis points versus year ago. Strong sales
of Colgate 360° Deep Clean and Colgate Max Fresh manual toothbrushes
throughout the region contributed to this success.
In other product categories, Colgate Plax Whitening and Colgate Plax Ice
mouthwashes, Palmolive bar soap and shower gel with ingredients from the
Amazon, Protex Aloe bar soap, Lady Speed Stick Aloe Defense multi-form
deodorants, Palmolive Caprice shampoo and Suavitel Magic Moments, a
fabric conditioner with a touch-release fragrance that lasts for months
after washing, contributed to market share gains in the region.
Europe/South Pacific (21% of Company
Sales)
As reported, Europe/South Pacific sales and unit volume declined 20.0%
and 4.0%, respectively. Excluding divested businesses, sales and unit
volume declined 19.5% and 3.5%, respectively. Pricing increased 1.5% and
foreign exchange was negative 17.5%. Organic sales for Europe/South
Pacific declined 2.0%. Volume gains in Australia, Romania, Czech
Republic and Greece were more than offset by volume declines in France,
Italy, Iberia, the United Kingdom and the GABA business. Operating
profit for the region declined 26% during the quarter, reflecting
negative foreign exchange and higher raw and packaging material costs
partially offset by lower advertising costs.
Colgate maintained its oral care leadership in the Europe/South Pacific
region with toothpaste share gains in Austria, Denmark, Germany, Greece,
Switzerland, Czech Republic, Ireland, the United Kingdom and Slovakia.
Successful premium products driving these share gains include Colgate
Max Fresh, Colgate Max White, Colgate Total Advanced Clean and Colgate
Sensitive Enamel Protect toothpastes. In the manual toothbrush category,
strong sales of Colgate 360° Deep Clean, Colgate Max Fresh and Colgate
Max White toothbrushes contributed to growth in the region.
Recent premium innovations contributing to growth in other product
categories include Colgate 360° Sonic Power battery toothbrush, Colgate
Plax Alcohol Free and Colgate Plax Ice mouth rinse, Ajax Professional
bucket dilutable and Ajax Professional glass cleaners, Lady Speed Stick
Aloe spray deodorant and Soupline Magic Moments fabric conditioner.
Greater Asia/Africa (18% of Company
Sales)
As reported, Greater Asia/Africa sales declined 3.0% and unit volume
increased 3.5%. Excluding divested businesses, Greater Asia/Africa sales
declined 2.5% and unit volume increased 4.0%. Volume gains were led by
India, Russia, Philippines, Vietnam, Turkey, South Africa, the Gulf
States/Saudi Arabia region and the Greater China region. Pricing
increased 7.5% and foreign exchange was negative 14.0%. Organic sales
for Greater Asia/Africa increased 11.5%. Operating profit for the region
increased 19% during the quarter due to higher pricing and lower
advertising costs, partially offset by negative foreign exchange and
higher raw and packaging material costs.
Colgate maintained its toothpaste leadership in Greater Asia with market
share gains in key countries throughout the region. In India, for
example, Colgate’s toothpaste market share reached 50.3% year to date,
up 180 basis points versus year ago. Successful new products driving the
share gains include Colgate Total Professional Clean, Colgate Max White,
Colgate Sensitive Enamel Protect and Darlie Sensitive Gum Protection
toothpastes.
New products contributing to growth in other categories in the region
include Colgate 360° Deep Clean and Colgate Max Fresh manual
toothbrushes, Colgate Plax Overnight Herbal Sensations mouthwash,
Palmolive Papaya Yogurt shower gel, bar soap and liquid hand soap,
Protex Aloe and Protex Icy Cool shower creams and bar soaps and Lady
Speed Stick Clinical deodorant.
Hill’s (14% of Company Sales)
Hill’s sales grew 0.5% during the quarter. Unit volume declined 7.0%,
pricing increased 14.0% and foreign exchange was negative 6.5%. Hill’s
organic sales rose 7.0% during the quarter. Volume growth in Russia,
Germany, Turkey, the Benelux countries and Austria was more than offset
by volume declines in the United States, France, Switzerland, the United
Kingdom and Canada. Operating profit increased 3% during the quarter due
to the benefits of higher pricing more than offsetting the impact of
higher raw and packaging material costs.
Products contributing to sales in the U.S. specialty channel include
Science Diet Nature’s Best Canine and Feline, Science Diet Mature Adult
Canine, new Science Diet Culinary Creations Feline and the relaunch of
Science Diet Puppy and Kitten dry foods with improved formulas including
higher levels of antioxidants clinically proven to build a healthier
immune system within 90 days. Prescription Diet j/d Canine contributed
to sales in the U.S. veterinary channel.
New pet food products contributing to international sales include
Science Plan Nature’s Best Canine and Feline in Europe, and the relaunch
of Science Diet Puppy and Kitten foods in Japan.
About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer
products company, tightly focused on Oral Care, Personal Care, Home Care
and Pet Nutrition. Colgate sells its products in over 200 countries and
territories around the world under such internationally recognized brand
names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex,
Sorriso, Kolynos, Elmex, Tom’s of Maine, Ajax, Axion, Fabuloso, Soupline
and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription
Diet. For more information about Colgate’s global business, visit the
Company's web site at http://www.colgate.com.
Unless otherwise indicated, all market share data included in this press
release is as measured by ACNielsen.
Cautionary Statement on Forward-Looking
Statements
This press release and the related webcast (other than historical
information) may contain forward-looking statements. Such statements may
relate, for example, to sales or volume growth, organic sales growth,
profit and profit margin growth, earnings growth, financial goals,
cost-reduction plans, tax rates and new product introductions. These
statements are made on the basis of our views and assumptions as of this
time and we undertake no obligation to update these statements. We
caution investors that any such forward-looking statements are not
guarantees of future performance and that actual events or results may
differ materially from those statements. Investors should consult the
Company’s filings with the Securities and Exchange Commission (including
the information set forth under the captions “Risk Factors” and
“Cautionary Statement on Forward-Looking Statements” in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2008) for
information about certain factors that could cause such differences.
Copies of these filings may be obtained upon request from the Company’s
Investor Relations Department or the Company’s web site at http://www.colgate.com.
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP measures used
in this earnings release:
To supplement Colgate's condensed consolidated income statements
presented in accordance with accounting principles generally accepted in
the United States of America (GAAP), the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Gross profit
margin, selling, general and administrative expenses, operating profit,
operating profit margin, net income and earnings per share are discussed
in this release both as reported (on a GAAP basis) and excluding the
impact of restructuring charges related to the restructuring program
that began in the fourth quarter of 2004 and was completed as of the end
of 2008 (the "2004 Restructuring Program"). These restructuring charges
include separation-related costs, incremental depreciation and asset
write-downs, and other costs related to the implementation of the 2004
Restructuring Program. In light of their nature and magnitude, the
Company believes these items should be presented separately to enhance
an investor’s overall understanding of its ongoing operations.
Management believes these non-GAAP financial measures provide useful
supplemental information to investors regarding the underlying business
trends and performance of the Company’s ongoing operations and are
useful for period-over-period comparisons of such operations. The
Company uses these financial measures internally in its budgeting
process and as factors in determining compensation. While the Company
believes that these financial measures are useful in evaluating the
Company’s business, this information should be considered as
supplemental in nature and is not meant to be considered in isolation or
as a substitute for the related financial information prepared in
accordance with GAAP. In addition, these non-GAAP financial measures may
not be the same as similar measures presented by other companies. See
“Consolidated Income Statement and Supplemental Information —
Reconciliation Excluding the 2004 Restructuring Program” for the three
months ended March 31, 2009 and 2008 included with this release for a
reconciliation of these financial measures to the related GAAP measures.
Sales and unit volume growth, both worldwide and in relevant geographic
divisions, are discussed in this release both as reported and excluding
divestments. Management believes this provides useful supplemental
information to investors as it allows comparisons of sales growth and
volume growth from ongoing operations on a period-over-period basis.
This release also discusses organic sales growth (excludes the impact of
foreign exchange, acquisitions and divestments). Management believes
this measure provides investors with useful supplemental information
regarding the Company’s underlying sales trends by presenting sales
growth excluding the external factor of foreign exchange as well as the
impact from acquisitions and divestments. See “Geographic Sales
Analysis, Percentage Changes – First Quarter 2009 vs. 2008” for a
comparison of sales excluding divestments and organic sales to sales as
reported in accordance with GAAP.
The Company defines free cash flow before dividends as net cash provided
by operations less capital expenditures. As management uses this measure
to evaluate the Company’s ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See “Condensed Consolidated Statements of
Cash Flows For the Three Months Ended March 31, 2009 and 2008” for a
comparison of free cash flow before dividends to net cash provided by
operations as reported in accordance with GAAP.
(See attached tables for first quarter results.)
|
Table 1
|
|
Colgate-Palmolive Company
|
|
|
|
Consolidated Income Statement and Supplemental Information
|
|
|
|
Reconciliation Excluding the 2004 Restructuring Program
|
|
|
|
For the Three Months Ended March 31, 2009 and 2008
|
|
|
|
(in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
2009
|
|
2008
|
|
|
|
As Reported
|
|
As Reported
|
|
Restructuring
|
|
Excluding Restructuring
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
3,502.8
|
|
$
|
3,713.0
|
|
$
|
-
|
|
$
|
3,713.0
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
1,490.4
|
|
|
1,613.2
|
|
|
25.9
|
|
|
1,587.3
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
2,012.4
|
|
|
2,099.8
|
|
|
(25.9)
|
|
|
2,125.7
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
57.5%
|
|
|
56.6%
|
|
|
|
|
57.3%
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
1,185.7
|
|
|
1,348.9
|
|
|
13.2
|
|
|
1,335.7
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net*
|
|
|
15.3
|
|
|
5.2
|
|
|
(0.7)
|
|
|
5.9
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
811.4
|
|
|
745.7
|
|
|
(38.4)
|
|
|
784.1
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit margin
|
|
|
23.2%
|
|
|
20.1%
|
|
|
|
|
21.1%
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
21.2
|
|
|
33.7
|
|
|
-
|
|
|
33.7
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
790.2
|
|
|
712.0
|
|
|
(38.4)
|
|
|
750.4
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
253.7
|
|
|
223.5
|
|
|
(17.2)
|
|
|
240.7
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
32.1%
|
|
|
31.4%
|
|
|
|
|
32.1%
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
536.5
|
|
|
488.5
|
|
|
-
|
|
|
509.7
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests*
|
|
|
28.6
|
|
|
22.0
|
|
|
-
|
|
|
22.0
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
507.9
|
|
|
466.5
|
|
|
(21.2)
|
|
|
487.7
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.00
|
|
$
|
0.90
|
|
$
|
(0.04)
|
|
$
|
0.94
|
|
Diluted
|
|
$
|
0.97
|
|
$
|
0.86
|
|
$
|
(0.04)
|
|
$
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
500.7
|
|
|
509.0
|
|
|
509.0
|
|
|
509.0
|
|
Diluted
|
|
|
526.2
|
|
|
539.5
|
|
|
539.5
|
|
|
539.5
|
|
|
|
*
|
The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of ARB
No. 51” (SFAS 160), on January 1, 2009. To conform to the current
year's presentation, net income attributable to noncontrolling
interests in less-than-wholly owned subsidiaries has been
reclassified from Other (income) expense, net to a new line below
Operating profit called Net income attributable to noncontrolling
interests. The reclassification had no effect on Net income or
Earnings per common share.
|
|
|
|
|
|
See Table 2 "Supplemental Consolidated Income Statement Information"
for a reconciliation to previously reported amounts for the three
months ended March 31, 2008. Refer to the Company's website for a
reconciliation to previously reported amounts for all quarters of
2008 as well as full year 2008 and 2007.
|
|
|
|
Note: The impact of "Restructuring” on the basic and diluted
earnings per share may not necessarily equal the earnings per share
if calculated independently as a result of rounding.
|
|
Table 2
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
Supplemental Consolidated Income Statement Information
|
|
|
|
Impact of the adoption of FASB Statement No. 160
|
|
|
|
For the Three Months Ended March 31, 2008
|
|
|
|
(in Millions) (Unaudited)
|
|
|
|
|
|
As Reported
|
|
Excluding Restructuring
|
|
|
|
Pre-Adoption of SFAS 160
|
|
Post-Adoption of SFAS 160
|
|
Impact of Adoption
|
|
Pre-Adoption of SFAS 160
|
|
Post-Adoption of SFAS 160
|
|
Impact of Adoption
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
3,713.0
|
|
$
|
3,713.0
|
|
$
|
-
|
|
$
|
3,713.0
|
|
$
|
3,713.0
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
1,613.2
|
|
|
1,613.2
|
|
|
-
|
|
|
1,587.3
|
|
|
1,587.3
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
2,099.8
|
|
|
2,099.8
|
|
|
-
|
|
|
2,125.7
|
|
|
2,125.7
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
56.6%
|
|
|
56.6%
|
|
|
-
|
|
|
57.3%
|
|
|
57.3%
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
1,348.9
|
|
|
1,348.9
|
|
|
-
|
|
|
1,335.7
|
|
|
1,335.7
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
27.2
|
|
|
5.2
|
|
|
(22.0)
|
|
|
27.9
|
|
|
5.9
|
|
|
(22.0)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
723.7
|
|
|
745.7
|
|
|
22.0
|
|
|
762.1
|
|
|
784.1
|
|
|
22.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit margin
|
|
|
19.5%
|
|
|
20.1%
|
|
+60 bps
|
|
|
20.5%
|
|
|
21.1%
|
|
+60 bps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
33.7
|
|
|
33.7
|
|
|
-
|
|
|
33.7
|
|
|
33.7
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
690.0
|
|
|
712.0
|
|
|
22.0
|
|
|
728.4
|
|
|
750.4
|
|
|
22.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
223.5
|
|
|
223.5
|
|
|
-
|
|
|
240.7
|
|
|
240.7
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
32.4%
|
|
|
31.4%
|
|
-100 bps
|
|
|
33.0%
|
|
|
32.1%
|
|
-90 bps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
466.5
|
|
|
488.5
|
|
|
22.0
|
|
|
487.7
|
|
|
509.7
|
|
|
22.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
|
-
|
|
|
22.0
|
|
|
22.0
|
|
|
-
|
|
|
22.0
|
|
|
22.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
466.5
|
|
$
|
466.5
|
|
$
|
-
|
|
$
|
487.7
|
|
$
|
487.7
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note: Refer to the Company's website for a reconciliation to
previously reported amounts for all quarters of 2008 as well as full
year 2008 and 2007.
|
|
Table 3
|
|
Colgate-Palmolive Company
|
|
|
|
Condensed Consolidated Balance Sheets
|
|
|
|
As of March 31, 2009, December 31, 2008 and March 31, 2008
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
December 31,
|
|
March 31,
|
|
|
|
|
2009
|
|
2008
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
702.2
|
|
$
|
554.9
|
|
$
|
642.1
|
|
|
Receivables, net
|
|
|
1,565.4
|
|
|
1,591.9
|
|
|
1,784.8
|
|
|
Inventories
|
|
|
1,199.4
|
|
|
1,197.1
|
|
|
1,287.0
|
|
|
Other current assets
|
|
|
349.9
|
|
|
366.1
|
|
|
374.3
|
|
|
Property, plant and equipment, net
|
|
|
3,054.7
|
|
|
3,119.5
|
|
|
3,082.3
|
|
|
Other assets, including goodwill and intangibles
|
|
|
3,061.7
|
|
|
3,149.8
|
|
|
3,638.9
|
|
|
Total assets
|
|
$
|
9,933.3
|
|
$
|
9,979.3
|
|
$
|
10,809.4
|
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
3,657.0
|
|
|
3,783.5
|
|
|
3,706.8
|
|
|
Other current liabilities
|
|
|
2,889.6
|
|
|
2,755.1
|
|
|
3,312.2
|
|
|
Other non-current liabilities**
|
|
|
1,447.8
|
|
|
1,397.4
|
|
|
1,405.3
|
|
|
Total liabilities
|
|
|
7,994.4
|
|
|
7,936.0
|
|
|
8,424.3
|
|
|
Total Colgate-Palmolive Company shareholders' equity
|
|
|
1,793.4
|
|
|
1,922.1
|
|
|
2,252.2
|
|
|
Noncontrolling interests**
|
|
|
145.5
|
|
|
121.2
|
|
|
132.9
|
|
|
Total liabilities and shareholders’ equity
|
|
$
|
9,933.3
|
|
$
|
9,979.3
|
|
$
|
10,809.4
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Balance Sheet Information
|
|
|
|
|
|
|
|
|
Debt less cash, cash equivalents and marketable securities*
|
|
$
|
2,930.1
|
|
$
|
3,216.4
|
|
$
|
3,051.1
|
|
|
Working capital % of sales
|
|
|
1.4%
|
|
|
2.5%
|
|
|
0.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Marketable securities of $24.7, $12.2 and $13.6 as of March 31,
2009, December 31, 2008 and March 31, 2008, respectively, are
included in Other current assets.
|
|
|
|
|
**
|
The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of
ARB No. 51” (SFAS 160), on January 1, 2009. To conform to the
current year's presentation, prior period balances of accumulated
undistributed earnings relating to noncontrolling interests in
less-than-wholly owned subsidiaries have been reclassified from
Other non-current liabilities to a component of shareholders'
equity.
Refer to the Company's website for a reconciliation to previously
reported amounts for all quarters of 2008 as well as full year
2008 and 2007.
|
|
Table 4
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
Condensed Consolidated Statements of Cash Flows
|
|
|
|
For the Three Months Ended March 31, 2009 and 2008
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
2009
|
|
2008
|
|
|
|
|
|
|
|
Operating Activities
|
|
|
|
|
|
Net income
|
|
$
|
507.9
|
|
|
$
|
466.5
|
|
|
Adjustments to reconcile net income to net cash provided by
operations:
|
|
|
|
|
|
Restructuring, net of cash
|
|
|
(6.6
|
)
|
|
|
(9.6
|
)
|
|
Depreciation and amortization
|
|
|
81.9
|
|
|
|
88.6
|
|
|
Stock-based compensation expense
|
|
|
38.5
|
|
|
|
27.1
|
|
|
Deferred income taxes
|
|
|
54.4
|
|
|
|
24.0
|
|
|
Cash effects of changes in:
|
|
|
|
|
|
Receivables
|
|
|
(14.9
|
)
|
|
|
(52.1
|
)
|
|
Inventories
|
|
|
(33.8
|
)
|
|
|
(88.7
|
)
|
|
Accounts payable and other accruals
|
|
|
2.8
|
|
|
|
106.4
|
|
|
Other non-current assets and liabilities
|
|
|
60.0
|
|
|
|
7.7
|
|
|
Net cash provided by operations
|
|
|
690.2
|
|
|
|
569.9
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
Capital expenditures
|
|
|
(73.2
|
)
|
|
|
(85.3
|
)
|
|
Sale of property and non-core product lines
|
|
|
3.6
|
|
|
|
12.8
|
|
|
Sales (purchases) of marketable securities and investments
|
|
|
(12.4
|
)
|
|
|
9.0
|
|
|
Other
|
|
|
0.4
|
|
|
|
(0.4
|
)
|
|
Net cash used in investing activities
|
|
|
(81.6
|
)
|
|
|
(63.9
|
)
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
Principal payments on debt
|
|
|
(771.4
|
)
|
|
|
(1,222.4
|
)
|
|
Proceeds from issuance of debt
|
|
|
710.5
|
|
|
|
1,336.6
|
|
|
Dividends paid
|
|
|
(202.7
|
)
|
|
|
(185.6
|
)
|
|
Purchases of treasury shares
|
|
|
(201.9
|
)
|
|
|
(306.2
|
)
|
|
Proceeds from exercise of stock options and excess tax benefits
|
|
|
10.4
|
|
|
|
78.1
|
|
|
Net cash used in financing activities
|
|
|
(455.1
|
)
|
|
|
(299.5
|
)
|
|
|
|
|
|
|
|
Effect of exchange rate changes on Cash and cash equivalents
|
|
|
(6.2
|
)
|
|
|
6.9
|
|
|
Net increase/(decrease) in Cash and cash equivalents
|
|
|
147.3
|
|
|
|
213.4
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
554.9
|
|
|
|
428.7
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
702.2
|
|
|
$
|
642.1
|
|
|
|
|
|
|
|
|
Supplemental Cash Flow Information
|
|
|
|
|
|
Free cash flow before dividends (net cash provided by operations
less capital expenditures)
|
|
|
|
Net cash provided by operations
|
|
$
|
690.2
|
|
|
$
|
569.9
|
|
|
Less: Capital expenditures
|
|
|
(73.2
|
)
|
|
|
(85.3
|
)
|
|
Free cash flow before dividends
|
|
$
|
617.0
|
|
|
$
|
484.6
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
102.3
|
|
|
$
|
109.2
|
|
|
|
Table 5
|
|
Colgate-Palmolive Company
|
|
|
|
Segment Information
|
|
|
|
For the Three Months Ended March 31, 2009 and 2008
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2009
|
|
2008
|
|
Net sales
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
729.7
|
|
|
$
|
709.5
|
|
|
Latin America
|
|
|
911.0
|
|
|
|
945.5
|
|
|
Europe/South Pacific
|
|
|
719.1
|
|
|
|
900.0
|
|
|
Greater Asia/Africa
|
|
|
636.6
|
|
|
|
654.8
|
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
$
|
2,996.4
|
|
|
$
|
3,209.8
|
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
|
506.4
|
|
|
|
503.2
|
|
|
|
|
|
|
|
|
Total Net sales
|
|
$
|
3,502.8
|
|
|
$
|
3,713.0
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2009
|
|
2008
|
|
Operating profit
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
191.6
|
|
|
$
|
164.1
|
|
|
Latin America
|
|
|
306.2
|
|
|
|
280.0
|
|
|
Europe/South Pacific
|
|
|
143.1
|
|
|
|
192.4
|
|
|
Greater Asia/Africa*
|
|
|
151.6
|
|
|
|
127.7
|
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
$
|
792.5
|
|
|
$
|
764.2
|
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
|
131.7
|
|
|
|
127.4
|
|
|
Corporate
|
|
|
(112.8
|
)
|
|
|
(145.9
|
)
|
|
|
|
|
|
|
|
Total Operating profit
|
|
$
|
811.4
|
|
|
$
|
745.7
|
|
|
|
|
|
|
|
|
*
|
|
The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of ARB
No. 51” (SFAS 160), on January 1, 2009. To conform to the current
year's presentation, net income attributable to noncontrolling
interests in less-than-wholly owned subsidiaries of $22.0 for the
three months ended March 31, 2008, which was previously deducted
from Greater Asia/Africa Operating profit, has been reclassified to
a new line below Operating profit.
|
|
|
|
|
|
Note:
|
|
The Company evaluates segment performance based on several
factors, including Operating profit. The Company uses Operating
profit as a measure of the operating segment performance because
it excludes the impact of corporate-driven decisions related to
interest expense and income taxes. Corporate operations include
restructuring and related implementation costs, stock-based
compensation related to stock options and restricted stock awards,
research and development costs, Corporate overhead costs, and
gains and losses on sales of non-core product lines and assets.
|
|
|
|
|
|
|
|
For the three months ended March 31, 2008, Corporate operating
expenses include $38.4 of charges related to the Company’s 2004
Restructuring Program.
|
|
Table 6
|
|
Colgate-Palmolive Company
|
|
|
|
Geographic Sales Analysis
|
|
|
|
Percentage Changes - First Quarter 2009 vs 2008
|
|
|
|
March 31, 2009
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE
|
|
|
|
|
|
|
|
|
|
FIRST QUARTER
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
1st Qtr
|
|
1st Qtr
|
|
|
|
|
|
Coupons
|
|
|
|
|
|
Sales
|
|
Sales
|
|
1st Qtr
|
|
|
|
Consumer &
|
|
|
|
|
|
Change
|
|
Change
|
|
Organic
|
|
Ex-Divested
|
|
Trade
|
|
|
|
Region
|
|
As Reported
|
|
Ex-Divestment
|
|
Sales Change
|
|
Volume
|
|
Incentives
|
|
Exchange
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
|
(5.5
|
%)
|
|
(5.0
|
%)
|
|
8.0
|
%
|
|
0.0
|
%
|
|
8.0
|
%
|
|
(13.0
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe/South Pacific
|
|
(20.0
|
%)
|
|
(19.5
|
%)
|
|
(2.0
|
%)
|
|
(3.5
|
%)
|
|
1.5
|
%
|
|
(17.5
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America
|
|
(3.5
|
%)
|
|
(3.5
|
%)
|
|
17.0
|
%
|
|
1.5
|
%
|
|
15.5
|
%
|
|
(20.5
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greater Asia/Africa
|
|
(3.0
|
%)
|
|
(2.5
|
%)
|
|
11.5
|
%
|
|
4.0
|
%
|
|
7.5
|
%
|
|
(14.0
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
(9.5
|
%)
|
|
(9.0
|
%)
|
|
8.5
|
%
|
|
0.5
|
%
|
|
8.0
|
%
|
|
(17.5
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
3.0
|
%
|
|
3.0
|
%
|
|
5.0
|
%
|
|
2.0
|
%
|
|
3.0
|
%
|
|
(2.0
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CP Products
|
|
(6.5
|
%)
|
|
(6.0
|
%)
|
|
8.0
|
%
|
|
1.0
|
%
|
|
7.0
|
%
|
|
(14.0
|
%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hill's
|
|
0.5
|
%
|
|
0.5
|
%
|
|
7.0
|
%
|
|
(7.0
|
%)
|
|
14.0
|
%
|
|
(6.5
|
%)
|

Colgate-Palmolive Company
Bina Thompson 212-310-3072
Hope
Spiller 212-310-2291